Columbia University

Running trials

• Not yet recruiting

  HIV/STI/HCV Testing and Overdose Prevention Among Survivors of Sex Trafficking

  NCT07264582· Source

• Not yet recruiting

  COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE"

  NCT07281027· Phase 3· Source

• Not yet recruiting

  The Study of Brave-LC LDN Treatment Trial

  NCT07916259· Phase 3· Source

• Not yet recruiting

  Modality Choice Before and After Failure for the Treatment of Painful Diabetic Neuropathy

  NCT07795593· Phase 4· Source

• Not yet recruiting

  Gestational Hypertension and Preeclampsia Blood Pressure (BP) Treatment Goals Less Than 140/90 vs. Less Than 160/110 mmHg: The GOALPOST Trial

  NCT07746271· Phase 3· Source

• Recruiting

  MediBeacon® Transdermal GFR System for the Evaluation of Kidney Function in Adults With Heart Failure

  NCT07349797· Source

• Recruiting

  Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG

  NCT07216391· Phase 2· Source

• Recruiting

  GBPDC: Gut-Brain in PD Consortium Master Protocol

  NCT07567794· Source

• Recruiting

  Pridopidine Phase 3 Study in Huntington's Disease

  NCT07609108· Phase 3· Source

• Recruiting

  Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

  NCT07142252· Phase 2· Source

• Recruiting

  MyPEEPS Mobile Plus: A Multi-Level HIV Prevention Intervention for Young MSM

  NCT06741618· Source

• Recruiting

  A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

  NCT07226843· Phase 1· Source

• Recruiting

  Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

  NCT07059091· Phase 2· Source

• Recruiting

  A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV

  NCT07392372· Phase 1· Source

• Recruiting

  Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma

  NCT07225621· Phase 2· Source

• Recruiting

  DRP-104 in Patients With NFE2L2/KEAP1-altered Non-Small Cell Lung Cancer

  NCT07249372· Phase 2· Source

• Enrolling by invitation

  A Long-Term Study of Bivamelagon in Participants With Hypothalamic Obesity (HO)

  NCT07156578· Phase 2· Source

• Recruiting

  A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer

  NCT07189403· Phase 1· Source

• Active, not recruiting

  Clinical Study of Neflamapimod in Patients With Primary Progressive Aphasia

  NCT07033481· Phase 2· Source

• Recruiting

  Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

  NCT07007312· Phase 3· Source

• Recruiting

  A Study of GNTI-122 in Adults Recently Diagnosed With T1D

  NCT06919354· Phase 1· Source

• Recruiting

  Comparing Traditional Semantic Feature Analysis (tSFA) and Semantic Feature Analysis + Metacognitive Strategy Training (SFA+MST)

  NCT07036406· Phase 2· Source

• Recruiting

  A Study of LY4175408 in Participants With Advanced Cancer

  NCT07046923· Phase 1· Source

• Recruiting

  FITting Non-invasive Tests in Lynch Syndrome Surveillance

  NCT06898996· Source

• Recruiting

  An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

  NCT06951217· Phase 2· Source

• Recruiting

  Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

  NCT06819007· Phase 3· Source

• Recruiting

  Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs

  NCT06532890· Source

• Recruiting

  Ending the HIV Epidemic: An All-facility Intervention for Patient and Healthcare Staff Well-being

  NCT05785169· Source

• Recruiting

  A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

  NCT06680830· Phase 2· Source

• Recruiting

  MyPEEPS LITE Trial

  NCT06741631· Source

• Recruiting

  Genetic and Environmental Risk Factors for Hemorrhagic Stroke

  NCT00682695· Source

• Recruiting

  P3 Trial: Estimating the Impact of a Multilevel, Multicomponent Intervention to Increase Uptake of HIV Testing and Biomedical HIV Prevention

  NCT06785376· Source

• Recruiting

  RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

  NCT06359041· Phase 1/2· Source

• Recruiting

  ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL

  NCT06693830· Source

• Recruiting

  Impella Reverse Remodeling in End-Stage Heart Failure

  NCT06800716· Source

• Active, not recruiting

  A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors

  NCT06607185· Phase 1· Source

• Recruiting

  Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL

  NCT06468202· Phase 4· Source

• Recruiting

  A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)

  NCT06526923· Phase 1/2· Source

• Recruiting

  Noise-augmented Automatic Speech Recognition for Speech Treatment in Parkinson's Disease

  NCT06540989· Early phase 1· Source

• Recruiting

  ASSESS ALL ALS Study

  NCT06578195· Source

• Active, not recruiting

  PREVENT ALL ALS Study

  NCT06581861· Source

• Recruiting

  Accelerated Age-related Cognitive Decline: Impact of Exercise on Executive Function and Neuroplasticity

  NCT05655325· Source

• Active, not recruiting

  A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)

  NCT06285643· Phase 2· Source

• Recruiting

  A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer

  NCT06457919· Phase 1/2· Source

• Recruiting

  Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)

  NCT06263426· Source

• Recruiting

  Long-Covid-19 Alleviation Through Learning Mindfulness Study

  NCT07140094· Source

• Active, not recruiting

  A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

  NCT06329401· Phase 2· Source

• Active, not recruiting

  Personalized Antisense Oligonucleotide Therapy for A Single Participant With ATN1 Gene Mutation

  NCT06706388· Phase 1/2· Source

• Enrolling by invitation

  Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria

  NCT06262282· Source

• Recruiting

  Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

  NCT04234048· Phase 1· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• HIV7 recruiting
• Lung cancer5 recruiting
• Parkinson disease5 recruiting
• ALS (motor neurone disease)4 recruiting
• Stroke4 recruiting
• Type 1 diabetes4 recruiting
• Colorectal cancer3 recruiting
• Heart failure3 recruiting
• Alzheimer disease2 recruiting
• Bladder cancer2 recruiting
• COPD2 recruiting
• Cystic fibrosis2 recruiting
• Diffuse large B-cell lymphoma2 recruiting
• Follicular lymphoma2 recruiting
• High blood pressure2 recruiting
• Huntington's disease2 recruiting
• Long COVID and ME/CFS2 recruiting
• Ovarian cancer2 recruiting
• Pancreatic cancer2 recruiting
• Prostate cancer2 recruiting
• Type 2 diabetes2 recruiting
• Acute myeloid leukemia1 recruiting
• Cervical cancer1 recruiting
• Chronic kidney disease1 recruiting
• Coronary artery disease1 recruiting
• Endometrial cancer1 recruiting
• Epilepsy1 recruiting
• Frontotemporal dementia1 recruiting
• Gastric and esophageal cancer1 recruiting
• Glioblastoma1 recruiting
• Hodgkin lymphoma1 recruiting
• Idiopathic pulmonary fibrosis1 recruiting
• Kidney cancer1 recruiting
• Melanoma1 recruiting
• Multiple myeloma1 recruiting
• Myasthenia gravis1 recruiting
• Myeloproliferative neoplasms1 recruiting
• Obesity1 recruiting
• Sickle cell disease1 recruiting
• Triple-negative breast cancer1 recruiting
• Tuberculosis1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 When Added to Trikafta

  NCT07108153· Phase 2· Source

• Completed

  REVEAL - Research With I-124 EVuzamitide to Elucidate Cardiac AmyLoidosis

  NCT06788535· Phase 3· Source

• Recruiting

  A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer

  NCT06562543· Phase 4· Source

• Completed

  A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity

  NCT06046443· Phase 2· Source

• Completed

  Community Health Worker Assisted Task Specific and Cognitive Therapy at Home With Exposure After Stroke

  NCT06314308· Source

• Completed

  Using Shared Decision Making to Improve Kidney Transplantation Rates

  NCT06141499· Source

• Completed

  Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension

  NCT06153693· Phase 3· Source

• Completed

  Improving Patient Prioritization During Hospital-homecare Transition

  NCT04136951· Source

• Completed

  Community Health Worker And MHealth to ImProve Viral Suppression (CHAMPS Pilot)

  NCT05938413· Source

• Completed

  MyPEEPS Mobile for Young Transgender Men

  NCT05424718· Source

• Completed

  A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen

  NCT05769608· Phase 2· Source

• Recruiting

  A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer

  NCT05365581· Phase 1· Source

• Completed

  Study to Evaluate the Safety, Tolerability and Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy Bodies

  NCT05225415· Phase 2· Source

• Terminated

  A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors

  NCT05355753· Phase 1· Source

• Terminated

  Pressure Enabled Delivery of SD-101 With Checkpoint Blockade for Primary Liver Tumors

  NCT05220722· Phase 1/2· Source

• Recruiting

  A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

  NCT04988555· Phase 1/2· Source

• Completed

  ASPIRES (Activating Cancer Survivors and Their Primary Care Providers to Increase Colorectal Cancer Screening) Study

  NCT05084833· Source

• Completed

  Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)

  NCT05259696· Phase 1/2· Source

• Completed

  Health e-Baby: Trial to Reduce Obesity Risk Factors During the First 1,000 Days

  NCT05225649· Source

• Completed

  EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway

  NCT05093634· Phase 3· Source

• Completed

  DAYBREAK: A Study of Setmelanotide in Participants With Specific Gene Variants in the Melanocortin-4 Receptor (MC4R) Pathway

  NCT04963231· Phase 2· Source

• Completed

  Understanding the Long-term Impact of COVID-19 in Adults (RECOVER)

  NCT05172024· Source

• Completed

  XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer

  NCT05005728· Phase 2· Source

• Completed

  Pre-exposure Prophylaxis Implementation in Central-Eastern European Countries

  NCT05323123· Source

• Completed

  Exploring the Effects of Spinal Cord Stimulation in Parkinson's Disease.

  NCT03526991· Source

• Completed

  TREAT to Improve Cardiometabolic Health

  NCT04465721· Source

• Completed

  Proof-of-concept Study for SAR445088 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  NCT04658472· Phase 2· Source

• Terminated

  A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer

  NCT04832854· Phase 2· Source

• Completed

  A Translational and Neurocomputational Evaluation of a Dopamine Receptor 1 Partial Agonist for Schizophrenia

  NCT04457310· Phase 2· Source

• Completed

  LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors

  NCT04666688· Phase 1/2· Source

• Completed

  A Communication Tool to Assist Older Adults Facing Dialysis Choices

  NCT04466865· Source

• Completed

  COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors.

  NCT04570839· Phase 1/2· Source

• Completed

  Trial of Parkinson's And Zoledronic Acid

  NCT03924414· Phase 4· Source

• Completed

  Anti-CD137 and Anti-CTLA-4 Monoclonal Antibody in Patients With Advanced Cancer

  NCT04121676· Phase 1· Source

• Completed

  Old School Hip Hop: Parent Follow-Up & Spanish Speakers Inclusion

  NCT06699589· Source

• Terminated

  Pravastatin to Prevent Preeclampsia

  NCT03944512· Phase 3· Source

• Completed

  An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy

  NCT03921528· Phase 2· Source

• Completed

  Alvelestat (MPH966) for the Treatment of ALpha-1 ANTitrypsin Deficiency

  NCT03679598· Phase 2· Source

• Completed

  COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.

  NCT03667716· Phase 1· Source

• Completed

  Study of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML

  NCT03258931· Phase 3· Source

• Terminated

  Open-Label Study of AG10 in Patients With Cardiomyopathy

  NCT03536767· Phase 2· Source

• Completed

  CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma

  NCT03425279· Phase 1/2· Source

• Terminated

  Body Composition and Adipose Tissue in HIV

  NCT03226821· Phase 4· Source

• Completed

  Nivolumab in Treating Patients With Stage IIB-IIC Melanoma That Can Be Removed by Surgery

  NCT03405155· Phase 2· Source

• Completed

  Milrinone in Congenital Diaphragmatic Hernia

  NCT02951130· Phase 2· Source

• Completed

  Recovery and Outcomes From Stroke

  NCT04007757· Source

• Completed

  A Study of Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer)

  NCT03193190· Phase 1/2· Source

• Completed

  Prospective Observational Cohort Study of Fetal Atrial Flutter & Supraventricular Tachycardia

  NCT03376438· Source

• Completed

  Study of Front Line Therapy With Nivolumab and Salvage Nivolumab + Ipilimumab in Patients With Advanced Renal Cell Carcinoma

  NCT03117309· Phase 2· Source

• Completed

  Oral Bacterial Extract for the Prevention of Wheezing Lower Respiratory Tract Illness

  NCT02148796· Phase 2· Source

Trial sites

• Columbia University157 trials
• Columbia University School of Nursing4 trials
• Columbia University Site Number : 84000051 trial
• Neuroendocrine Unit and Pituitary Center, Columbia University1 trial
• Teachers College, Columbia University3 trials
• The Neurological Institute of New York, Columbia University1 trial
• University of Columbia1 trial

Conditions

Diseases this institution publishes on or runs trials for.

• Alzheimer disease359 works · 8 trials
• HIV326 works · 11 trials
• Stroke174 works · 7 trials
• Heart failure136 works · 5 trials
• Obesity123 works · 7 trials
• Asthma81 works · 1 trials
• Schizophrenia70 works · 1 trials
• Parkinson disease69 works · 9 trials
• Melanoma50 works · 6 trials
• Epilepsy49 works · 2 trials
• Atrial fibrillation48 works · 0 trials
• Depression44 works · 0 trials
• Amyloidosis36 works · 3 trials
• Pancreatic cancer35 works · 7 trials
• Glioblastoma33 works · 5 trials
• ALS (motor neurone disease)31 works · 7 trials
• Autism30 works · 0 trials
• COPD28 works · 4 trials
• Osteoporosis26 works · 1 trials
• Cervical cancer26 works · 1 trials
• Hodgkin lymphoma25 works · 2 trials
• Bipolar disorder25 works · 0 trials
• Glaucoma23 works · 1 trials
• Long COVID and ME/CFS21 works · 3 trials
• Endometrial cancer16 works · 4 trials
• Sickle cell disease13 works · 1 trials
• Endometriosis11 works · 0 trials
• Childhood cancers11 works · 7 trials
• Diffuse large B-cell lymphoma10 works · 3 trials
• Spinal muscular atrophy10 works · 3 trials